Post Profile






Dr. Mohamad Cherry of Atlantic Hematology Oncology to Lead Meeting Session and Help Present Multiple Studies at Top International Blood Cancer Meeting

Mohamad Cherry, MD, will lead a major session on new discoveries about the most common type of acute adult leukemia and help present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA. The meeting is the world's pre-eminent gathering of clinicians and researchers focused on blood diseases, who travel from nearly 100 countries to hear the latest research developments.
read more

share
See more about: American Society

Related Posts


John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH Meeting

Health : Newswise Medical News

Researchers from the Hackensack Merdian Health John Theurer Cancer Center at Hackensack University Medical Center will present results from 46 cancer-related studies during the American Society of Hematology (ASH) 59th Annual Meetin...

Immunotherapy Strategy Could Be Beneficial for Relapsed Acute Myeloid Leukemia, Preliminary Data Show

Health : Newswise Medical News

Researchers present their preliminary results from the ongoing phase II trial of chemotherapy and pembrolizumab in relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta on...

MD Anderson to Present Key Drug Study Findings for Multiple Blood Cancers at ASH Annual Meeting

Health : Newswise Medical News

Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for blood cancers at the American Society of Hematology's (ASH) Annual Meeting & Exposition Dec. 8-12 in A...

Bioengineering and specialized therapies yield results for rare, challenging blood diseases

Health : EurekAlert: Health

(American Society of Hematology) In four studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers announce promising findings on innovative tools and th...

Targeted therapies show promise improving outcomes across several hematologic malignancies

Health : EurekAlert: Health

(American Society of Hematology) Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple ways in which novel targeted cancer therapies are n...

Comments


Copyright © 2016 Regator, LLC